{
    "2019-04-18": [
        [
            {
                "time": "2019-04-30",
                "original_text": "【天风医药】鱼跃医疗：核心业务快速增长，公司领先优势愈加显著",
                "features": {
                    "keywords": [
                        "鱼跃医疗",
                        "核心业务",
                        "快速增长",
                        "领先优势"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "无视减持利空 谁在助推四连板的兴齐眼药",
                "features": {
                    "keywords": [
                        "兴齐眼药",
                        "减持",
                        "四连板",
                        "利空"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "一季度成绩单出炉，面对“第二批带量采购”恒瑞医药选择这样做",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "带量采购",
                        "一季度",
                        "成绩单"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "【东吴医药】恒瑞医药2019年一季报点评：收入端增长加速，研发力度加大，符合预期",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "一季报",
                        "收入增长",
                        "研发力度",
                        "符合预期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "122家药企晒一季度成绩单",
                "features": {
                    "keywords": [
                        "药企",
                        "一季度",
                        "成绩单"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "恒瑞医药2019一季报点评:业绩符合预期,创新再度提速",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "一季报",
                        "业绩",
                        "创新",
                        "提速"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "4月以来，恒瑞、华北制药等多家药企发布一季报",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "华北制药",
                        "一季报"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "恶性肿瘤黑色素瘤 谁能将其完全“洗白”？",
                "features": {
                    "keywords": [
                        "恶性肿瘤",
                        "黑色素瘤",
                        "治疗"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "经济底确定意味着什么？ 创新类股权有望获回报",
                "features": {
                    "keywords": [
                        "经济底",
                        "创新类股权",
                        "回报"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "经济",
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "2019年一季度QFII持仓曝光 星湖科技等6只潜力股成新宠",
                "features": {
                    "keywords": [
                        "QFII",
                        "持仓",
                        "星湖科技",
                        "潜力股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "其他"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "恒瑞医药:业绩基本符合预期,持续加码研发投入",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "业绩",
                        "研发投入",
                        "符合预期"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}